Invention Grant
US09266872B2 2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient
有权
2-羟基芳基酰胺衍生物或其药学上可接受的盐,其制备方法和用于预防或治疗含有其的活性成分的癌症的药物组合物
- Patent Title: 2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient
- Patent Title (中): 2-羟基芳基酰胺衍生物或其药学上可接受的盐,其制备方法和用于预防或治疗含有其的活性成分的癌症的药物组合物
-
Application No.: US14256808Application Date: 2014-04-18
-
Publication No.: US09266872B2Publication Date: 2016-02-23
- Inventor: Semi Kim , Ill Young Lee , Hye-Jin Min , Eun-Hee Nam , Pilho Kim , Chang Soo Yun , Dong Joon Ko
- Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
- Applicant Address: KR
- Assignee: Korea Research Institute of Bioscience and Biotechnology
- Current Assignee: Korea Research Institute of Bioscience and Biotechnology
- Current Assignee Address: KR
- Agency: Sheridan Ross P.C.
- Priority: KR10-2011-0107934 20111021; KR10-2012-0116733 20121019
- Main IPC: A61K31/167
- IPC: A61K31/167 ; A61K31/426 ; C07D417/04 ; C07D215/38 ; C07D285/135 ; C07D213/75 ; C07D239/42 ; C07D277/46 ; C07D213/82 ; C07D215/56 ; C07D277/82 ; A61K31/4439 ; A61K31/428 ; A61K31/433 ; A61K31/44 ; A61K31/4709 ; A61K31/505 ; A61K31/5377

Abstract:
The present invention relates to a 2-hydroxyarylamide derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition for preventing or treating cancer comprising the same as an active ingredient. The 2-hydroxyarylamide derivative prepared by the present invention is excellent in the inhibition of the activity of TMPRSS4 serine protease and the suppression of the infiltration of TMPRSS4-expressed cancer cells, and thus can be useful as a composition for preventing or treating cancer by inhibiting TMPRSS4 over-expressed in cancer cells, particularly, colorectal cancer, lung cancer, breast cancer, prostate cancer, ovarian cancer, pancreatic cancer, or stomach cancer cells.
Public/Granted literature
Information query